Vivos Therapeutics Inc. (NASDAQ:VVOS) said physician-owned practices supported by its Nevada-based management services subsidiary have obtained in-network status with several commercial insurers as well as participating provider status with Medicare.
The network agreements include coverage from Medicare, TRICARE, UnitedHealthcare, UMR, Intermountain Health, Select Health, CareSource, Anthem, Aetna, Cigna, Health Plan of Nevada, Humana, Molina and Wellcare. Together, these insurers represent a significant share of the insured population in the Las Vegas metropolitan area.
The Colorado-based medical device company develops therapies for obstructive sleep apnea using its Complete Airway Repositioning and Expansion devices, which have received FDA 510(k) clearance for treating severe OSA in adults and moderate to severe OSA in children aged 6 to 17.
“Previously, many OSA patients who were excited about Vivos treatment as an alternative to CPAP were denied coverage by their insurance company or Medicare,” said CEO Kirk Huntsman. According to the company, supported practices have already evaluated thousands of patients who may now be re-contacted following the expansion of insurance coverage.
In a separate development, Vivos said it began implementing cost-cutting measures in February 2026, including reductions in headcount and adjustments to vendor relationships tied to its legacy dental-focused distribution structure.
The company estimates the initiatives could generate about $4 million in annualized cost savings, although the actual level of savings may vary.
Vivos added that the combination of broader insurance access and reduced operating costs is expected to lower its cash burn rate and help the company move toward achieving positive cash flow during fiscal year 2026.